Numerical chromosome aberrations in gametes typically lead to failed fertilization, spontaneous abortion or a chromosomally abnormal fetus. By means of preimplantation genetic diagnosis (PGD), we now can screen human embryos in vitro for aneuploidy before transferring the embryos to the uterus. PGD allows us to select unaffected embryos for transfer and increases the implantation rate in in vitro fertilization programs. Molecular cytogenetic analyses using multi-color fluorescence in situ hybridization (FISH) of blastomeres have become the major tool for preimplantation genetic screening of aneuploidy. However, current FISH technology can test for only a small number of chromosome abnormalities and hitherto failed to increase the pregnancy rates as expected. We are in the process of developing multi-color FISH-based technologies to score all 24 chromosomes in single cells within a three-day time limit, which we believe is vital to the clinical setting. Also, human placental cytotrophoblasts (CTBs) at the fetal-maternal interface acquire aneuploidies as they differentiate to an invasive phenotype. About 20–50% of invasive CTB cells from uncomplicated pregnancies were found to be aneuploid, suggesting that the acquisition of aneuploidy is an important component of normal placentation, perhaps limiting the proliferative and invasive potential of CTBs. Since most invasive CTBs are interphase cells and possess extreme heterogeneity, we applied multi-color FISH and repeated hybridizations to investigate the feasibility of a full karyotype analysis of individual CTBs. In summary, this study demonstrates the strength of Spectral Imaging analysis and repeated hybridizations, which provides a basis for full karyotype analysis of single interphase cells.

1.
Bahçe M, Escudero T, Sandalinas M, Morrison L, Legator M, Munné S: Improvements of preimplantation diagnosis of aneuploidy by using microwave hybridization, cell recycling and monocolour labelling of probes. Mol Hum Reprod 9:849–854 (2000).
2.
Barrett IJ, Lomax BL, Loukianova T, Tang SS, Lestou VS, Kalousek DK: Comparative genomic hybridization: a new tool for reproductive pathology. Arch Pathol Lab Med 125:81–84 (2001).
3.
Bryndorf T, Christensen B, Vad M, Parner J, Brocks V, Philip J: Prenatal detection of chromosome aneuploidies by fluorescence in situ hybridization: experience with 2000 uncultured amniotic fluid samples in a prospective preclinical trial. Prenat Diagn 17:333–341 (1997).
4.
Damsky CH, Fitzgerald ML, Fisher SJ: Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway in vivo. J Clin Invest 89:210–222 (1992).
5.
Erlich HA: Principles and applications of the polymerase chain reaction. Rev Immunogenet 1:127–134 (1999).
6.
Fisher SJ, Cui TY, Zhang L, Hartman L, Grahl K, Zhang GY, Tarpey J, Damsky CH: Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol 109:891–902 (1989).
7.
Fung J, Hyun W, Dandekar P, Pedersen RA, Weier H-UG: Spectral imaging in preconception/ preimplantation genetic diagnosis (PGD) of aneuploidy: multi-colour, multi-chromosome screening of single cells. J Assisted Reprod Genet 15:322–329 (1998).
8.
Fung J, Weier H-UG, Goldberg JD, Pedersen RA: Multilocus genetic analysis of single interphase cells by spectral imaging. Hum Genet 107:615–622 (2000).
9.
Fung J, Munné S, Weier H-UG: Detection of chromosome translocation products in single interphase cell nuclei, in Darzynkiewicz Z, Chrissman HA, Robinson JP (eds): Methods in Cell Biology, Vol 64, Part B, Cytometry, 3rd Ed, pp 97–114 (Academic Press, San Diego 2001a).
10.
Fung J, Weier H-UG, Pedersen RA, Zitzelsberger HF: Spectral imaging analysis of metaphase and interphase cells, in Rautenstrauss B, Liehr T (eds): FISH Technology. FISH Technology – Springer Lab Manual, Chapter 29, pp 363–387 (Springer, Berlin 2001b).
11.
Garini Y, Macville M, du Manoir S, Buckwald RA, Lavi M, Katzir N, Wine D, Bar-Am I, Schröck E, Cabib D, Ried T: Spectral karyotyping. Bioimaging 4:65–72 (1996).
12.
Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, Cheville JC, Sebo TJ, et al: A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 164:1768–1775 (2000).
13.
Harper M, Saunders G: Localization of single copy DNA sequences on G-banded human chromosomes by in situ hybridization. Chromosoma 83:431–439 (1981).
14.
Hassold T, Chen N, Funkhouser J, Jooss T, Manuel B, Matsuura J, Matsuyama A, Wilson C, Yamane JA, Jacobs PA: A cytogenetic study of 1000 spontaneous abortions. Ann Hum Genet Lond 44:151–178 (1980).
15.
Hassold T, Warburton D, Kline J, Stein Z: The relationship of maternal age and trisomy among trisomic spontaneous abortions. Am J Hum Genet 36:1349–1356 (1984).
16.
Henderson KG, Shaw TE, Barrett IJ, Telenius AH, Wilson RD, Kalousek DK: Distribution of mosaicism in human placentae. Hum Genet 97:650–654 (1996).
17.
Hook EB: Chromosome anomalies: prevalence, risks, and recurrence, in Brock DJH, Rodeck CH, Ferguson Smith MA (eds): Prenatal Diagnosis and Screening, pp 351–392 (Churchill Livingstone, Edinburgh 1992).
18.
Hopman AH, Wiegant J, Raap AK, Landegent JE, van der Ploeg M, van Duijn P: Bi-color detection of two target DNAs by non-radioactive in situ hybridization. Histochemistry 85:1–4 (1986).
19.
Jenkins TM, Wapner RJ: First trimester prenatal diagnosis: chorionic villus sampling. Semin Perinatol 23:403–413 (1999).
20.
Jenkins RB, Le Beau MM, Kraker WJ, Borell TJ, Stalboerger PG, Davis EM, Penland L, Fernald A, Espinosa R 3rd, Schaid DJ: Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens. Blood 79:3307–3315 (1992).
21.
Kuo WL, Tenjin H, Segraves R, Pinkel D, Golbus MS, Gray J: Detection of aneuploidy involving chromosomes 13, 18, or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes. Am J Hum Genet 49:112–119 (1991).
22.
Ledbetter DH, Zachary JM, Simpson JL, Golbus MS, Pergament E, Jackson L, Mahoney MJ, Desnick RJ, Schulman J, Copeland KL, et al: Cytogenetic results from the U.S. Collaborative Study on CVS. Prenat Diagn 12:317–345 (1992).
23.
Lestou VS, Kalousek DK: Confined placental mosaicism and intrauterine fetal growth. Arch Dis Child Fetal Neonatal Ed 79:F223–226 (1998).
24.
Lestou VS, Desilets V, Lomax BL, Barrett IJ, Wilson RD, Langlois S, Kalousek DK: Comparative genomic hybridization: a new approach to screening for intrauterine complete or mosaic aneuploidy. Am J Med Genet 92:281–284 (2000).
25.
Levy B, Papenhausen P, Tepperberg J, Dunn T, Fallet S, Magid M, Kardon N, Hirschhorn K, Warburton P: Prenatal molecular cytogenetic diagnosis of partial tetrasomy 10p due to neocentromere formation in an inversion duplication analphoid marker chromosome. Cytogenet Cell Genet 91:165–170 (2000).
26.
Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH, Fisher SJ: 92-kDa type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 113:437–449 (1991).
27.
Lomax B, Tang S, Separovic E, Phillips D, Hillard E, Thomson T, Kalousek DK: Comparative genomic hybridization in combination with flow cytometry improves results of cytogenetic analysis of spontaneous abortions. Am J Hum Genet 66:1516–1521 (2000).
28.
MacAuley A, Cross JC, Werb Z: Reprogramming the cell cycle for endoreduplication in rodent trophoblast cells. Mol Biol Cell 9:795–807 (1998).
29.
Márquez C, Cohen J, Munné S: Chromosome identification in human oocytes and polar bodies by spectral karyotyping. Cytogenet Cell Genet 81:254–258 (1998).
30.
Moyzis RK, Albright KL, Bartholdi MF, Cram LS, Deaven LL, Hildebrand CE, Joste NE, Longmire JL, Meyne J, Schwarzacher-Robinson T: Human chromosome-specific repetitive DNA sequences: novel markers for genetic analysis. Chromosoma 95:375–386 (1987).
31.
Munné S, Weier U: Simultaneous enumeration of chromosomes X, Y, 18, 13, and 21 in interphase cells for preimplantation genetic diagnosis of aneuploidy. Cytogenet Cell Genet 75:263–270 (1996).
32.
Munné S, Lee A, Rosenwaks Z, Grifo J, Cohen J: Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum Reprod 8:2185–2191 (1993).
33.
Munné S, Magli C, Bahçe M, Fung J, Legator M, Morrison L, Cohert J, Gianaroli L: Preimplantation diagnosis of the aneuploidies most commonly found in spontaneous abortions and live births: XY, 13, 14, 15, 16, 18, 21, 22. Prenat Diagn 18:1459–1466 (1998).
34.
Munné S, Magli C, Cohen J, Morton P, Sadowy S, Gianaroli L, Tucker M, Márquez C, Sable D, Ferraretti AP, Massey JB, Scott R: Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Hum Reprod 14:2191–2199 (1999).
35.
Nakayama H, Scott IC, Cross JC: The transition to endoreduplication in trophoblast giant cells is regulated by the mSNA zinc finger transcription factor. Dev Biol 199:150–163 (1998).
36.
Nietzel A, Rocchi M, Starke H, Heller A, Fiedler W, Wlodarska I, Loncarevic IF, Beensen V, Claussen U, Liehr T: A new multicolor-FISH approach for the characterization of marker chromosomes: centromere-specific multicolor-FISH (cenM-FISH). Hum Genet 108:199–204 (2001).
37.
Ning Y, Laundon CH, Schröck E, Buchanan P, Ried T: Prenatal diagnosis of a mosaic extra structurally abnormal chromosome by spectral karyotyping. Prenat Diagn 19:480–482 (1999).
38.
Santaló J, Veiga A, Calafell JM, Calderon G, Vidal F, Barri PN, Gimenes C, Egozcue J: Evaluation of cytogenetic analysis for clinical preimplantation diagnosis. Fertil Steril 64:44–50 (1995).
39.
Schröck E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter D, Bar-Am I, Soenksen D, Garini Y, Ried T: Multicolor spectral karyotyping of human chromosomes. Science 273:494–497 (1996).
40.
Sermon K, Van Steirteghem A, Liebaers I: Preimplantation genetic diagnosis. Lancet 363:1633–1641 (2004).
41.
Tabet AC, Aboura A, Dauge MC, Audibert F, Coulomb A, Batallan A, Couturier-Turpin MH, Feldmann G, Tachdjian G: Cytogenetic analysis of trophoblasts by comparative genomic hybridization in embryo-fetal development anomalies. Prenat Diagn 21:613–618 (2001).
42.
Tarkowski AK: An air drying method for chromosome preparation from mouse eggs. Cytogenetics 5:394–400 (1966).
43.
Verlinsky Y, Cieslak J, Ivakhnenko V, Evsikov S, Wolf G, White M, Lifchez A, Kaplan B, Moise J, Valle J, Ginsberg N, Strom C, Kuliev A: Preimplantation diagnosis of common aneuploidies by the first- and second-polar body FISH analysis. J Assist Reprod Genet 15:285–289 (1998a).
44.
Verlinsky Y, Cieslak J, Ivakhnenko V, Evsikov S, Wolf G, White M, Lifchez A, Kaplan B, Moise J, Valle J, Ginsberg N, Strom C, Kuliev A: Prepregnancy genetic testing for age-related aneuploidies by polar body analysis. Genet Testing 1:231–235 (1998b).
45.
Wakuda K, Yoshida Y: DNA ploidy and proliferative characteristics of human trophoblasts. Acta Obstet Gynecol Scand 71:12–16 (1992).
46.
Walch A, Bink K, Hutzler P, Bowering K, Letsiou I, Zitzelsberger H, Braselmann H, Stein H, Hoefler H, Werner M: Sequential multilocus fluorescence in situ hybridization can detect complex patterns of increased gene dosage at the single cell level in tissue sections. Lab Invest 81:1457–1459 (2001).
47.
Weier JF, Weier H-UG, Jung JJ, Gormley M, Zhou Y, Chu LW, Genbacev O, Wright AA, Fisher SJ: Human cytotrophoblasts acquire aneuploidies as they differentiate to an invasive phenotype. Dev Biol 279:420–432 (2005).
48.
Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G, Lathrop M: A second-generation linkage map of the human genome. Nature 359:794–801 (1992).
49.
Wells D, Delhanty JD: Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. Mol Hum Reprod 6:1055–1062 (2000).
50.
Wells D, Escudero T, Levy B, Hirschhorn K, Delhanty JD, Munne S: First clinical application of comparative genomic hybridization and polar body testing for preimplantation genetic diagnosis of aneuploidy. Fertil Steril 78:543–549 (2002).
51.
Yu LC, Moore DH 2nd, Magrane G, Cronin J, Pinkel D, Lebo RV, Gray JW: Objective aneuploidy detection for fetal and neonatal screening using comparative genomic hybridization (CGH). Cytometry 28:191–197 (1997).
52.
Zhen DK, Wang JY, Falco VM, Weber W, Delli-Bovi L, Bianchi DW: Poly-FISH: A technique of repeated hybridizations that improves cytogenetic analysis of fetal cells in maternal blood. Prenat Diagn 18:1181–1185 (1998).
53.
Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M, Damsky CH: Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 99:2139–2151 (1997).
54.
Zitzelsberger H, Lehmann L, Hieber L, Weier H-UG, Janish C, Fung J, Negele T, Spelsberg F, Lengfelder E, Demidchik E, Salassidis K, Kellerer AM, Werner M, Bauchinger M: Cytogenetic changes in radiation-induced tumors of the thyroid. Cancer Res 59:135–140 (1999).
55.
Zitzelsberger H, Bruch J, Smida J, Hieber L, Peddie CM, Bryant PE, Riches AC, Fung J, Weier HU, Bauchinger M: Clonal chromosomal aberrations in simian virus 40-transfected human thyroid cells and in derived tumors developed after in vitro irradiation. Int J Cancer 96:166–177 (2001).
56.
Zybina TG, Kaufmann P, Frank HG, Freed J, Kadyrov M, Biesterfeld S: Genome multiplication of extravillous trophoblast cells in human placenta in the course of differentiation and invasion into endometrium and myometrium. I. Dynamics of polyploidization. Tsitologiia 44:1058–1067 (2002).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.